JCM
MED icon

Julex Capital Management’s Medifast MED Stock Holding History

Julex Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1K Buy
+12
New +$1.29K ﹤0.01% 162

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Julex Capital Management's MED Position: Q3 2019 in Review

Julex Capital Management opened a new position in Medifast (MED) in Q3 2019: 12 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #162 among its holdings.

239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Julex Capital Management held 12 shares of Medifast worth $1K as of Q3 2019.
  • Medifast was a new Julex Capital Management position in Q3 2019.
  • Medifast made up ﹤0.01% of Julex Capital Management's portfolio in Q3 2019, its #162 holding.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Julex Capital Management's 13F filing for Q3 2019, filed 18 Oct 2019.